title: Artificial neural network cascade identifies multi-P450 inhibitors in natural compounds.
abstract: Substantial evidence has shown that most exogenous substances are metabolized by multiple cytochrome P450 (P450) enzymes instead of by merely one P450 isoform. Thus, multi-P450 inhibition leads to greater drug-drug interaction risk than specific P450 inhibition. Herein, we innovatively established an artificial neural network cascade (NNC) model composed of 23 cascaded networks in a ladder-like framework to identify potential multi-P450 inhibitors among natural compounds by integrating 12 molecular descriptors into a P450 inhibition score (PIS). Experimental data reporting in vitro inhibition of five P450 isoforms (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) were obtained for 8,148 compounds from the Cytochrome P450 Inhibitors Database (CPID). The results indicate significant positive correlation between the PIS values and the number of inhibited P450 isoforms (Spearman's ρ = 0.684, p < 0.0001). Thus, a higher PIS indicates a greater possibility for a chemical to inhibit the enzyme activity of at least three P450 isoforms. Ten-fold cross-validation of the NNC model suggested an accuracy of 78.7% for identifying whether a compound is a multi-P450 inhibitor or not. Using our NNC model, 22.2% of the approximately 160,000 natural compounds in TCM Database@Taiwan were identified as potential multi-P450 inhibitors. Furthermore, chemical similarity calculations suggested that the prevailing parent structures of natural multi-P450 inhibitors were alkaloids. Our findings show that dissection of chemical structure contributes to confident identification of natural multi-P450 inhibitors and provides a feasible method for virtually evaluating multi-P450 inhibition risk for a known structure.
authors.affiliation: Department of Pharmacy Administration, Harbin Medical University , Harbin , China.
authors.forename: Zhangming
authors.initials: Z
authors.lastname: Li
authors.affiliation: Department of Pharmacy, The Fourth Hospital of Harbin Medical University , Harbin , China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.affiliation: Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology , Shanghai , China.
authors.forename: Lu
authors.initials: L
authors.lastname: Sun
authors.affiliation: Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology , Shanghai , China.
authors.forename: Yun
authors.initials: Y
authors.lastname: Tang
authors.affiliation: Department of Pharmacy Administration, Harbin Medical University , Harbin , China.
authors.forename: Lanru
authors.initials: L
authors.lastname: Liu
authors.affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University , Harbin , China.
authors.forename: Wenliang
authors.initials: W
authors.lastname: Zhu
keywords: Multi-P450 inhibitor; Natural compound; Neural network cascade; P450